North American Cannabis Stock Index Already Up 5% In 2017

Analysis originally distributed on February 8, 2017 By: Michael Vodicka of Cannabis Stock Trades

Cannabis stocks are off to a good start in 2017.

After gaining 4.2% in January, the MJIC North American Cannabis Stock Index is now up more than 5% on the year.

Although that’s a great return for any ‘normal’ stock index, it might not jump off the page after cannabis stocks delivered big returns in 2016.

However, looking below the surface, you’ll see plenty of cannabis stocks have been burning up the charts in 2017.

Canadian cannabis stocks have been leading the pack.

Canopy Growth Corp (TSX:WEED), Canada’s largest medical cannabis company, is up 25% in 2017.

That bullish movement has been driven by a steady stream of good news. Continue reading "North American Cannabis Stock Index Already Up 5% In 2017"

Canada's Only Legal Monopoly Is Up 360% In 12 Months

Analysis originally distributed on February 1, 2017 By: Michael Vodicka of Cannabis Stock Trades

If you want to invest in a legal monopoly – I’ve got just the cannabis stock for you.

This early industry leader is the only Canadian cannabis stock with a license to produce and sell cannabis in Alberta – Canada’s fast-growing and fourth-largest province with a population of 4.1 million.

It just reported record first-quarter results, with revenue up 151% from just last quarter.

And finally, it’s in the early stages of building an 800,000 square foot, state of the art, cultivation center.

When you add it all together, this early industry leader is one of the most exciting stocks in the cannabis sector.

Aurora Cannabis Inc. (NASDAQ:ACBFF) is the second largest medical cannabis company in Canada with a market cap of $650 million.

Aurora currently operates a 55,200 square foot cultivation facility in Mountain View County. Continue reading "Canada's Only Legal Monopoly Is Up 360% In 12 Months"

Analysts Predicting a 58% Gain for this Leading Cannabis Biotech

Analysis originally distributed on January 25, 2017 By: Michael Vodicka of Cannabis Stock Trades

The cannabis industry is loaded with dozens of biotechs.

For example, if you take a look at the North American cannabis sector, you’ll see that the field is littered with biotechs such as Axim Biotechnologies (OTC:AXIM), Cara Therapeutics (Nasdaq:CARA) and Insys Therapeutics (Nasdaq:INSY).

These companies are aggressively searching for a cannabis-based medicine to treat some of the worst diseases plaguing humankind, including cancer, epilepsy, and HIV.

It’s obvious the cannabis industry sees a big opportunity in pharmaceuticals and is investing billions in research and development to cash in.

On the one hand, it’s great that investors have so many cannabis biotechs to choose from.

On the other, investing in biotech stocks is already one of the hardest sectors to pick winners and losers.

It’s even harder in the cannabis sector.

Some of these early cannabis biotechs will go on to make billions on blockbuster drugs and deliver market-crushing returns to shareholders.

Others will crumble and file for bankruptcy.

Today, I want to share my #1 cannabis biotech stock that I believe is ready to soar in 2017. Continue reading "Analysts Predicting a 58% Gain for this Leading Cannabis Biotech"

This $64 Million Cannabis Landlord is Cashing Fat Rent Checks

Analysis originally distributed on January 18, 2017 By: Michael Vodicka of Cannabis Stock Trades

Investing in real estate has been one of the best ways to get wealthy in the United States for the last 100 years.

In Forbes' 2016 list of the 400 richest people in America, real estate ranks as the sixth most common source of wealth.

This is just one more reason I am bullish on a new cannabis stock I like to call The Cannabis Landlord.

Innovative Industrial Properties (NYSE:IIPR) is a fresh face in the cannabis stock sector.

This undercover cannabis stock caught my attention for three reasons. Continue reading "This $64 Million Cannabis Landlord is Cashing Fat Rent Checks"

Profit From Dispensaries With A Micro-Cap Up 218% In 12 Months

Analysis originally distributed on January 11, 2017 By: Michael Vodicka of Cannabis Stock Trades

Dispensaries are staples of the cannabis industry.

This is where customers go to buy medical and recreational cannabis. Without these key players, there would be no retail outlet for cannabis consumers. After all, Wal-Mart isn’t carrying anyone’s favorite line of Kush. Not yet at least.

While dispensaries are important and highly visible in the distribution channel, they are also turning out to be one of the most profitable sub industries in the cannabis sector.

Dispensaries on the whole are doing well. And awesome in some cases.

According to a report from Marijuana Business Daily in mid-2016, almost 90% of cannabis dispensaries are profitable or breaking even. Take a look at the chart below.

90% of cannabis dispensaries are profitable
Chart courtesy of Marijuana Business Daily

What you can also see is that from the five cannabis sub-industries – dispensaries rank near the top in percent of profitable companies. Continue reading "Profit From Dispensaries With A Micro-Cap Up 218% In 12 Months"